v3.26.3
Collaboration, Out-Licensing and Related Agreements - Additional Information (Detail)
$ in Thousands, € in Millions
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 10 Months Ended 12 Months Ended
Nov. 09, 2024
Jun. 30, 2025
USD ($)
Jun. 30, 2025
EUR (€)
May 31, 2025
Doctor
Nov. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2024
EUR (€)
Mar. 31, 2024
USD ($)
Feb. 28, 2023
USD ($)
Feb. 28, 2023
EUR (€)
Mar. 31, 2021
USD ($)
Sep. 30, 2020
EUR (€)
Apr. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Sep. 30, 2026
USD ($)
Mar. 31, 2026
USD ($)
Sep. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2020
USD ($)
Sep. 30, 2026
EUR (€)
Dec. 31, 2023
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Other accrued liabilities                             $ 474       $ 474   $ 4,605      
Selling, general and administrative expenses related party amount                             43,520   $ 74,751   193,303 $ 170,167        
Financing liability                             75,208       75,208   72,140      
Revenue under collaboration agreements                             37,710   32,501   94,049 56,191        
Japan [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Revenue under collaboration agreements                                     5,995          
EEA License [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Performance obligation, transaction price         $ 69,400                                      
ROW License [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Performance obligation, transaction price         73,100                                      
Development and Regulatory Services [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Performance obligation, transaction price         2,600                                      
Alfresa Agreement [Member] | License Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Initial Transaction Price                         $ 7,000                      
Revenue under collaboration agreements                             0   0   0 0        
Alfresa Agreement [Member] | License Agreement [Member] | Japan [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Upfront Payment                         $ 2,000 $ 2,000         15,000          
License Agreement Expiration Term                         10 years                      
Regulatory milestone payment                         $ 5,000                      
Recordati Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Royalty expense payable                             300   100   500 200        
Recordati Agreement [Member] | Location, Statement of Income, Balance [Axis]: us-gaap:ResearchAndDevelopmentExpense                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Milestone Payments           $ 2,100 € 2.0                                  
Recordati Agreement [Member] | License Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Upfront Payment                                           $ 11,800    
Regulatory milestone payment                                           $ 6,000    
Recordati Agreement [Member] | Termination Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Upfront Payment                 $ 3,300 € 3.0                            
Aggregate milestone payments   $ 5,900 € 5.0                                          
Estimated Life of Finite Lived Intangible Assets   13 years 6 months 13 years 6 months                                          
Revenue recognized under the ALK Collaboration Agreement                                         0      
Recordati Agreement [Member] | Termination Agreement [Member] | Location, Statement of Income, Balance [Axis]: us-gaap:ResearchAndDevelopmentExpense                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Upfront Payment | €                       € 3.0                        
Recordati Agreement [Member] | In Process Research and Development [Member] | Termination Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Contract with Customer, Liability                                               $ 3,100
Recordati Agreement [Member] | European Medicines Agency [Member] | Termination Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Milestone Payments | €                   2.0                            
Recordati Agreement [Member] | First commercial sale of Recordati Licensed Product [Member] | Termination Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Milestone Payments | €                   5.0                            
Recordati Agreement [Member] | Aggregate sale of Recordati Licensed Product [Member] | Termination Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Royalty payments                   € 5.0         4,700       4,700       € 4.1  
Pediatrix Agreement [Member] | License Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
License Agreement Expiration Term                     10 years                          
Initial Transaction Price                     $ 3,000                          
Upfront payment and achievement of regulatory and commercial milestones                             7,000       7,000          
Revenue under collaboration agreements                             0   0   0 0        
Pediatrix Agreement [Member] | License Agreement [Member] | Maximum [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Sales-Based Milestones                                     80,000          
Seqirus Agreement [Member] | License Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
License Agreement Expiration Term               15 years                                
Initial Transaction Price               $ 500                                
Upfront payment and achievement of regulatory and commercial milestones                             3,900       3,900          
Commercial milestone payment                             1,300       1,300          
Revenue under collaboration agreements                                 0     0        
Seqirus Agreement [Member] | License Agreement [Member] | Maximum [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Regulatory and commercial milestones payments                                   $ 1,000            
ALK Collaboration Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Contract with Customer, Liability                             1,558       1,558   $ 1,739      
Upfront payment and achievement of regulatory and commercial milestones                             155,000       $ 155,000          
ALK Collaboration Agreement [Member] | License Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Upfront Payment         $ 145,000                                      
License Agreement Expiration Term         15 years                           15 years          
Regulatory milestone payment                               $ 5,000                
Regulatory and Commercial Sales Milestones         $ 20,000                                      
Revenue under collaboration agreements                               $ 2,500                
Purchase Commitment Period 5 years                                              
ALK Collaboration Agreement [Member] | License Agreement [Member] | Maximum [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Regulatory milestone payment         10,000                           $ 10,000          
Sales-Based Milestones         300,000                           300,000          
ALK Collaboration Agreement [Member] | EEA License [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Financing liability                             74,200       74,200          
ALK Collaboration Agreement [Member] | Development and Regulatory Services [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Contract with Customer, Liability                             2,500       2,500          
Revenue under collaboration agreements                             100   100   300 300        
ALK Collaboration Agreement [Member] | First Commercial Sale Of Neffy [Member] | License Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Upfront payment and achievement of regulatory and commercial milestones         $ 10,000                                      
ALK Co-Promotion Agreement [Member]                                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                                
Number of pediatricians | Doctor       10,000                                        
Performance based bonus payments percentage       30.00%                                        
Transaction under agreement with A.L.K U.S       Payments to ALK U.S. for the services performed during the first year of the arrangement will be deferred and paid in the second year of the arrangement. In addition to the base fee, ALK U.S. will be eligible to receive performance-based bonus payments from the Company starting in the second year of the arrangement equal to 30% of the portion of neffy net sales generated from the ALK U.S.-targeted prescribers in excess of a specified initial market share threshold in year two or a 50% market share threshold during years three and four of the arrangement.                                        
Threshold percentage       50.00%                                        
Selling, general and administrative expenses related party amount                                 $ 2,400     $ 3,800        
Co-promotion agreement expense                             $ 1,500       $ 6,800